Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Pectasides

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
American Journal of Clinical Oncology|February 20, 1999
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology GroupD V Skarlos, E Samantas, D Pectasides, et al.
Anticancer Research|June 3, 2006
HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapyD Pectasides, A Gaglia, P Arapantoni-Dadioti, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Immunoscintigraphy with 131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patientsD Pectasides, K Pateniotis, L Tzimis, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Immunoscintigraphy with 131I-labelled HMFG2 and HMFG1 F(ab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patientsA Athanassiou, D Pectasides, K Pateniotis, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Immunoscintigraphy with 131I-labelled H17E2 monoclonal antibody compared with conventional lymphangiography and computed tomography in the detection of metastases in patients with testicular germ cell tumoursD Pectasides, P Vonorta, A Tsialta-Salihou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2007
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experienceD Pectasides, G Fountzilas, G Aravantinos, et al.
British Journal of Cancer|June 1, 1986
Antibody-guided irradiation of malignant pleural and pericardial effusionsD Pectasides, S Stewart, N Courtenay-Luck, et al.
Cancer Investigation|December 13, 2006
Cisplatin-based chemotherapy for merkel cell carcinoma of the skinD Pectasides, M Pectasides, A Psyrri, et al.
Lung Cancer (Amsterdam, Netherlands)|August 19, 2007
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology GroupD Pectasides, E Samantas, G Fountzilas, et al.
Lung Cancer (Amsterdam, Netherlands)|April 27, 1999
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancerE Samantas, D V Skarlos, D Pectasides, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
American Journal of Clinical Oncology|February 20, 1999
Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology GroupD V Skarlos, E Samantas, D Pectasides, et al.
Anticancer Research|June 3, 2006
HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapyD Pectasides, A Gaglia, P Arapantoni-Dadioti, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Immunoscintigraphy with 131I-labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patientsD Pectasides, K Pateniotis, L Tzimis, et al.
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1988
Immunoscintigraphy with 131I-labelled HMFG2 and HMFG1 F(ab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patientsA Athanassiou, D Pectasides, K Pateniotis, et al.
The British Journal of Cancer. Supplement|July 1, 1990
Immunoscintigraphy with 131I-labelled H17E2 monoclonal antibody compared with conventional lymphangiography and computed tomography in the detection of metastases in patients with testicular germ cell tumoursD Pectasides, P Vonorta, A Tsialta-Salihou, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 21, 2007
Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experienceD Pectasides, G Fountzilas, G Aravantinos, et al.
British Journal of Cancer|June 1, 1986
Antibody-guided irradiation of malignant pleural and pericardial effusionsD Pectasides, S Stewart, N Courtenay-Luck, et al.
Cancer Investigation|December 13, 2006
Cisplatin-based chemotherapy for merkel cell carcinoma of the skinD Pectasides, M Pectasides, A Psyrri, et al.
Lung Cancer (Amsterdam, Netherlands)|August 19, 2007
Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology GroupD Pectasides, E Samantas, G Fountzilas, et al.
Lung Cancer (Amsterdam, Netherlands)|April 27, 1999
Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancerE Samantas, D V Skarlos, D Pectasides, et al.
Pageof 13